Cargando…

Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction

OBJECTIVES: Despite coherent guidelines, management of functional tricuspid regurgitation (FTR) consequences on outcome in the context of degenerative mitral regurgitation (DMR) remains controversial due to lacking series of large magnitude with rigorous application of tricuspid guidelines and stric...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreyfus, Gilles D., Essayagh, Benjamin, Benfari, Giovanni, Dulguerov, Filip, Haley, Shelley Rahman, Dommerc, Carine, Albert, Adelin, Enriquez-Sarano, Maurice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390475/
https://www.ncbi.nlm.nih.gov/pubmed/36003759
http://dx.doi.org/10.1016/j.xjon.2021.07.010
_version_ 1784770662994280448
author Dreyfus, Gilles D.
Essayagh, Benjamin
Benfari, Giovanni
Dulguerov, Filip
Haley, Shelley Rahman
Dommerc, Carine
Albert, Adelin
Enriquez-Sarano, Maurice
author_facet Dreyfus, Gilles D.
Essayagh, Benjamin
Benfari, Giovanni
Dulguerov, Filip
Haley, Shelley Rahman
Dommerc, Carine
Albert, Adelin
Enriquez-Sarano, Maurice
author_sort Dreyfus, Gilles D.
collection PubMed
description OBJECTIVES: Despite coherent guidelines, management of functional tricuspid regurgitation (FTR) consequences on outcome in the context of degenerative mitral regurgitation (DMR) remains controversial due to lacking series of large magnitude with rigorous application of tricuspid guidelines and strict long-term echocardiographic follow-up. Thus, we aimed at gathering such a cohort to examine outcomes of patients undergoing DMR surgery following tricuspid surgery guidelines. METHODS: All consecutive patients with isolated DMR 2005-2015 operated on with baseline FTR assessment and tricuspid annulus diameter measurement were identified. Operative complications, postoperative tricuspid regurgitation incidence, and survival were assessed overall and stratified by guideline-based tricuspid annuloplasty (TA) indication (severe FTR or tricuspid annulus diameter ≥40 mm). RESULTS: Among 441 patients with DMR undergoing mitral repair (66 ± 13 years, 30% female, ejection fraction 66 ± 10%, systolic pulmonary artery pressures 39 ± 12 mm Hg) followed 6 [3-9] years, patients with TA (n = 234, 53%) had generally similar presentation versus without TA (n = 207, 47%; all P ≥ .2) except for more atrial fibrillation and larger left ventricle (both P ≥ .0003). Patients with TA showed longer bypass time, more maze procedures (all P ≤ .001), but hospital stay, renal-failure, pacemaker implantation, and operative mortality (overall 0.9%) were comparable (all P ≥ .2). Postoperative incidence of moderate/severe FTR (0% at 1 year) became over time greater among patients without TA (5-year 8% [4%-13%] vs 3% [1%-11%] and 10-year 10% [6%-16%] vs 4% [1%-16%], P = .01). Survival (95% confidence interval) throughout follow-up was 85% (77%-89%) at 10 years, with hazard ratio 0.57 (0.29-1.10), P = .09. for patients with TA versus without. CONCLUSIONS: In this large surgical DMR cohort, guideline-based FTR management was safe and effective. While long-term mortality did not reach significance, postoperative incidence of moderate/severe FTR, overall low, was nevertheless greater in patients who did not appear to require TA at surgery and linked to tricuspid annular dimension. Thus, future multicenter prospective cohorts with long-term follow-up are warranted to re-examine thresholds for TA performance and impact on survival.
format Online
Article
Text
id pubmed-9390475
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-93904752022-08-23 Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction Dreyfus, Gilles D. Essayagh, Benjamin Benfari, Giovanni Dulguerov, Filip Haley, Shelley Rahman Dommerc, Carine Albert, Adelin Enriquez-Sarano, Maurice JTCVS Open Adult: Tricuspid Valve OBJECTIVES: Despite coherent guidelines, management of functional tricuspid regurgitation (FTR) consequences on outcome in the context of degenerative mitral regurgitation (DMR) remains controversial due to lacking series of large magnitude with rigorous application of tricuspid guidelines and strict long-term echocardiographic follow-up. Thus, we aimed at gathering such a cohort to examine outcomes of patients undergoing DMR surgery following tricuspid surgery guidelines. METHODS: All consecutive patients with isolated DMR 2005-2015 operated on with baseline FTR assessment and tricuspid annulus diameter measurement were identified. Operative complications, postoperative tricuspid regurgitation incidence, and survival were assessed overall and stratified by guideline-based tricuspid annuloplasty (TA) indication (severe FTR or tricuspid annulus diameter ≥40 mm). RESULTS: Among 441 patients with DMR undergoing mitral repair (66 ± 13 years, 30% female, ejection fraction 66 ± 10%, systolic pulmonary artery pressures 39 ± 12 mm Hg) followed 6 [3-9] years, patients with TA (n = 234, 53%) had generally similar presentation versus without TA (n = 207, 47%; all P ≥ .2) except for more atrial fibrillation and larger left ventricle (both P ≥ .0003). Patients with TA showed longer bypass time, more maze procedures (all P ≤ .001), but hospital stay, renal-failure, pacemaker implantation, and operative mortality (overall 0.9%) were comparable (all P ≥ .2). Postoperative incidence of moderate/severe FTR (0% at 1 year) became over time greater among patients without TA (5-year 8% [4%-13%] vs 3% [1%-11%] and 10-year 10% [6%-16%] vs 4% [1%-16%], P = .01). Survival (95% confidence interval) throughout follow-up was 85% (77%-89%) at 10 years, with hazard ratio 0.57 (0.29-1.10), P = .09. for patients with TA versus without. CONCLUSIONS: In this large surgical DMR cohort, guideline-based FTR management was safe and effective. While long-term mortality did not reach significance, postoperative incidence of moderate/severe FTR, overall low, was nevertheless greater in patients who did not appear to require TA at surgery and linked to tricuspid annular dimension. Thus, future multicenter prospective cohorts with long-term follow-up are warranted to re-examine thresholds for TA performance and impact on survival. Elsevier 2021-07-20 /pmc/articles/PMC9390475/ /pubmed/36003759 http://dx.doi.org/10.1016/j.xjon.2021.07.010 Text en © 2021 The Authors. Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Adult: Tricuspid Valve
Dreyfus, Gilles D.
Essayagh, Benjamin
Benfari, Giovanni
Dulguerov, Filip
Haley, Shelley Rahman
Dommerc, Carine
Albert, Adelin
Enriquez-Sarano, Maurice
Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction
title Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction
title_full Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction
title_fullStr Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction
title_full_unstemmed Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction
title_short Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction
title_sort outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction
topic Adult: Tricuspid Valve
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390475/
https://www.ncbi.nlm.nih.gov/pubmed/36003759
http://dx.doi.org/10.1016/j.xjon.2021.07.010
work_keys_str_mv AT dreyfusgillesd outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection
AT essayaghbenjamin outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection
AT benfarigiovanni outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection
AT dulguerovfilip outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection
AT haleyshelleyrahman outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection
AT dommerccarine outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection
AT albertadelin outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection
AT enriquezsaranomaurice outcomeofconsistentguidelinebasedtricuspidmanagementinpatientsundergoingdegenerativemitralregurgitationcorrection